Memory Loss and Cognitive Decline
You start noticing it before you mention it to anyone. A name that takes longer than it should to surface. Standing in a room you just walked into, unsure why you came. Losing the thread of a conversation you were a moment ago following clearly. You write it off at first, because the explanations are easy: too busy, not enough sleep, a lot going on. Then you start keeping track, and the list gets longer.
The physiological changes that eventually produce Alzheimer's disease, vascular dementia, and other forms of cognitive decline begin ten to twenty years before symptoms are obvious enough to diagnose. During most of that time, something can be done. The question is whether anyone is looking. Standard care tends to wait for a diagnosis before acting, because the treatments available at that stage are medication-based and appropriate once the disease is present. The decade or more before that point is where a different kind of evaluation and intervention makes a real difference.
We use a dedicated neurocognitive intake, advanced functional medicine testing, and evidence-based protocols developed through decades of clinical research on reversible cognitive decline to identify what is driving the change in your case and address it before it becomes fixed.
Cognitive decline has more than one cause
Alzheimer's disease and other dementias develop through several different physiological processes, and the combination varies from person to person. Identifying which processes are active in a given case and addressing those specifically produces far better results than a one-size approach. These are the factors we evaluate and address:
Inflammation
Chronic low-grade inflammation in the brain is one of the most consistent findings in cognitive decline. It can come from gut permeability, food sensitivities, chronic infections, or systemic inflammatory load. Standard inflammatory markers often read normal in people with significant neuroinflammation, because routine panels are not designed to detect it at the level it affects the brain.
Insulin resistance and blood sugar dysregulation
The brain depends heavily on glucose metabolism. Insulin resistance disrupts that process at the cellular level, and the connection is direct enough that some researchers now describe Alzheimer's as a metabolic disease of the brain. Fasting insulin resistance develops years before glucose moves out of the standard normal range, so routine bloodwork misses it entirely during the period when addressing it does the most good.
Hormonal changes
Declining estrogen, testosterone, thyroid hormone, and DHEA, an adrenal hormone that supports brain tissue repair, reduce the brain's ability to maintain and repair itself. These changes are gradual and often go unaddressed because standard hormone panels test a narrow slice of what matters clinically. A complete picture requires testing that shows how hormones are produced, converted, and cleared, not just their circulating level at one point in time.
Vascular and circulatory factors
The brain is the most metabolically demanding organ in the body, and anything that reduces blood flow, oxygen delivery, or waste clearance accumulates as damage over time. Blood pressure, sleep apnea, cardiovascular health, and homocysteine, an amino acid that damages artery walls when it accumulates, all factor in. Sleep is particularly significant: the glymphatic system, which clears protein waste from brain tissue, operates almost entirely during deep sleep. Disrupted sleep quality is one of the most consistent findings in people with early cognitive change.
Toxic and biotoxin burden
Heavy metals, mold toxins, and environmental chemical exposures accumulate in the nervous system and produce cognitive symptoms that are often attributed to aging or stress instead. Standard care does not routinely test for these. When toxic burden is the primary driver, identifying it reshapes the entire treatment approach, and addressing it without that identification accomplishes very little.
Nutrient deficiencies and methylation
B12, folate, vitamin D, omega-3 fatty acids, magnesium, and zinc all play direct roles in brain function and neuronal repair. Deficiencies are common and correctable. Methylation is the biochemical process the body uses to activate and switch off genes, produce neurotransmitters, and clear homocysteine from circulation. When it is disrupted, which happens in a significant portion of people with cognitive decline, and is frequently addressable with targeted nutritional support.
How the evaluation works
We start with a comprehensive intake that includes a dedicated neurocognitive assessment. It maps the specific pattern of your symptoms against the physiological factors above, because the pattern points toward the cause and the cause determines the plan. We also take a detailed history covering sleep quality, cardiovascular history, toxic exposures, hormonal history, gut function, and family history of cognitive disease.
From there we run advanced functional medicine testing targeted to what your history and symptom pattern suggest. Depending on your case, this typically includes fasting insulin and glucose, a full thyroid panel, comprehensive hormone testing, inflammatory markers beyond standard CRP, which is the routine inflammation marker most labs run, homocysteine, nutrient levels, and where indicated, testing for heavy metals, mold toxins, and genetic markers including APOE status.
Those results tell us which factors are active and how significant each one is. We build a structured plan around that, using nutritional and supplement protocols, dietary changes, sleep optimization, exercise guidance, stress physiology support, acupuncture for nervous system regulation and sleep quality, and chiropractic care where structural or circulatory factors are part of the picture. We measure your progress at each follow-up against the specific markers and symptoms that brought you in. When something is not moving, we say so and adjust the plan.
Why timing matters
The earlier the evaluation, the more of the damage is still functional rather than structural, and functional damage responds to intervention in ways that structural damage does not. Insulin resistance can be reversed. Inflammation can be reduced. Nutrient deficiencies can be corrected. Hormonal support can restore what has declined. Toxic burden can be cleared. Each of these is a real clinical outcome, not a general wellness goal, and each one is more achievable earlier in the process.
APOE4 is a genetic variant that raises susceptibility to Alzheimer's disease. Carrying it does not fix the outcome. What they do is make it more important to address the other factors well. That is exactly what this evaluation is designed to do.
If you have noticed changes in your thinking or memory, even changes that feel minor or come and go, an evaluation now gives you more options than waiting for them to worsen.
Common questions
My doctor says my memory concerns are normal for my age. Why would this be different?
Age-related cognitive change is real, but the rate and pattern of decline vary enormously depending on the physiological factors driving it. Insulin resistance, thyroid dysfunction, hormonal decline, and nutrient deficiencies all accelerate cognitive aging and are not inevitable. Identifying and addressing them changes the trajectory. A normal result on a standard cognitive screen does not rule out early dysfunction any more than a normal fasting glucose rules out insulin resistance.
What is the difference between this evaluation and a neuropsychological assessment?
A neuropsychological assessment measures how your cognitive function compares to population norms. It tells you where you stand relative to others your age. Our evaluation looks for the physiological factors driving the change: what is causing the decline, not just how much has occurred. Both have value. They address different questions.
Does APOE4 mean I will develop Alzheimer's disease?
No. APOE4 raises the statistical risk of Alzheimer's disease and influences how aggressively the other contributing factors should be addressed, but it does not determine outcome. Many people with APOE4 never develop Alzheimer's. Many people without it do. The modifiable factors — insulin resistance, inflammation, hormonal status, toxic burden, and nutrient sufficiency — matter more than the genetic variant when it comes to what you can actually do.
Can this help someone who has already been diagnosed with mild cognitive impairment?
Yes. Mild cognitive impairment sits between normal aging and dementia, and it is one of the highest-yield stages for this kind of evaluation. The contributing factors are still active and still addressable. The earlier in the disease course this work begins, the more functional reserve remains to protect.
Do I need a referral to come in for this evaluation?
No referral is needed. You schedule directly. If you are already working with a neurologist, we coordinate with them and share findings. We do not replace your existing care.
Services involved in this care plan
Functional Medicine Acupuncture Chiropractic CareAlso see: The decade before a diagnosis | Why we test differently | Brain fog | Thyroid and Hashimoto's | Blood sugar and insulin resistance
Schedule an appointment or call 704-663-2010.
